NCT03493542 2024-12-31
V501-213
Merck Sharp & Dohme LLC
Phase 3 Completed
Clinical Trials
23 trialsNCT03721978 2024-10-17
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Inovio Pharmaceuticals
Phase 3 Completed
NCT03185013 2023-07-27
REVEAL 1
Inovio Pharmaceuticals
Phase 3 Completed
NCT02733068 2022-12-19
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
Shanghai Zerun Biotechnology Co.,Ltd
Phase 3 Completed
NCT02330471 2022-07-08
CONE-1
Ruhr University of Bochum
Phase 3 Completed
NCT00000758 2021-11-04
A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3 Completed
NCT00001073 2021-11-04
Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3 Completed
NCT03355820 2020-11-19
A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
GlaxoSmithKline
Phase 3 Completed
NCT01735006 2020-02-24
Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine
Xiamen University
Phase 3 Completed
NCT00128661 2019-03-08
Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
GlaxoSmithKline
Phase 3 Completed
NCT01131312 2018-11-20
Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT02346227 2018-10-12
KINVAV
Universiteit Antwerpen
Phase 3 Completed
NCT00337818 2017-05-30
Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women
GlaxoSmithKline
Phase 3 Completed
NCT00212381 2017-03-29
Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia
New York Presbyterian Hospital
Phase 3 Completed
NCT00973362 2017-01-06
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System
Gen-Probe, Incorporated
Phase 3 Completed
NCT01929993 2015-07-23
A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins
Oswaldo Cruz Foundation
Phase 3 Completed
NCT00995020 2015-07-10
Efficacy Study of Diathermy Cone Biopsy for the Treatment of Cervical Intraepithelial Lesion
Oswaldo Cruz Foundation
Phase 3 Completed
NCT00462813 2013-08-07
Diindolylmethane in Treating Patients With Abnormal Cervical Cells
National Cancer Institute (NCI)
Phase 3 Completed
NCT01505920 2013-01-15
Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial
Chiang Mai University
Phase 3 Completed
NCT00316706 2012-09-18
Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine
GlaxoSmithKline
Phase 3 Completed
NCT01014026 2011-05-13
APACHE-1
University Hospital, Tours
Phase 3 Completed
NCT00156026 2009-01-29
Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed
NCT00237562 2006-05-05
Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit
University of California, Irvine
Phase 3 Completed